Media coverage: Phase I/II clinical trial in retinitis pigmentosa

Proactive Investors : CFO ‘pleased’ with reformulation of degenerative diseases treatment

To view the full article click here…

First Retinal Patient Receives Stem-Cell Therapy in ReNeuron’s Clinical Trial

For the article published by the Foundation for Fighting Blindness Click here..

Interview with Dr. Michael Young, pre-clinical investigator with ReNeuron’s hRPC retinal technology

https://soundcloud.com/trouttalks/trouttalks-ep7-dr-michael-young-human-retinal-progenitor-cell-therapy

Interview with Dr. Eric Pierce, Principal Investigator on ReNeuron’s Phase I/II clinical trial for Retinitis Pigmentosa

https://soundcloud.com/trouttalks/trouttalks-ep8-dr-eric-pierce-treatment-of-retinitis-pigmentosa

Pro-Active Investors : ReNeuron making good progress in clinical trials, says CFO

https://www.youtube.com/watch?v=gs_br8c1p2g

CFO gives interview at Proactive Investors after ReNeuron announces first patient treated in US Phase I/II clinical trial in retinitis pigmentosa

It is hoped that ReNeuron’s treatment will “at the very least” arrest the deterioration in eyesight caused by the disease and in the best case restore sight.

https://www.youtube.com/watch?v=hgHAKO9Cwkw

Multimedia Interview with Michael Hunt, ReNeuron Chief Executive Officer – 30th August 2013

Visit page: http://reut.rs/14J5zqc

Section: News

Filter by: